Welcome to the
EVER Pharma Webinar
Platform.
We are happy to have you here!
Treatment strategies for motor impaired stroke patients
Motor impairments after stroke affects about 80% of all stroke patients and the development of effective therapies is therefore a very important goal in acute and subacute rehabilitation. Recently, several national and international guidelines have started to include pharmacological agents as well, as there is evidence that the combination of physiotherapy with evidence-based agents such as Cerebrolysin is beneficial for the long-term outcome. In this webinar, the moderator Dr. Maciej Niewada from Warsaw, Poland will give the audience a brief update on stroke guidelines. Dr. Cathy Stinear, who is renowned worldwide for her research efforts in the field of motor...
Our Webinars
#stroke
Treatment strategies for motor impaired stroke patients
#tbi
Multidisciplinary Neurotrauma treatment - Panel Discussion about clinical reality and implementation strategies
On Demand
#stroke
Cerebroprotective strategies in acute ischemic stroke - fiction or reality?
#stroke
The future of chronic stroke patient treatment - Interactive case discussions
#tbi
Neurorecovery - When evidence from the bench meets results at the bedside
#neurocognitive disorders
Treating cognitive decline after critical illnesses - A call to action
#stroke
New horizons improving gold standard therapy in acute stroke - Case discussions
#stroke
Get with the guidelines in post-stroke motor recovery - Expert panel discussion
#tbi
Evidence-based neurorecovery after stroke and TBI
#stroke
The renaissance of neuroprotection in times of recanalization therapies
#tbi
Innovative strategies to advance severe TBI treatment
#stroke